Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The published research literature has investigated: GHRH receptor activation in pituitary somatotroph cells Pulsatile release of endogenous growth hormone Subsequent IGF-1 elevation through downstream GH signaling Maintained natural feedback regulation through somatostatin and IGF-1 DPP-4-resistant pharmacokinetics from the trans-3-hexenoic acid modification The two compounds produce fundamentally different research effects: AOD-9604 produces lipolytic activity without affecting IGF-1 or broader GH-mediated signaling Tesamorelin produces full GH axis activation including IGF-1 elevation and broader GH-mediated effects Pharmacokinetic Comparison The compounds have different pharmacokinetic profiles: AOD-9604
Every treatment plan is customized to the needs, health goals, and lifestyle of the individual in question, from dosage to delivery method and follow-up protocol
May your reconstitutions stay precise, your concentrations stay accurate, and your protocols stay consistent.
No serious long-term side effects have been reported from regular therapeutic use
Thats common if the injection happened during a check-up and wasnt the main reason for the visit
US$ 24.91
US$ 27.04
US$ 25.92
US$ 24.04
US$ 27.98
US$ 20.48
US$ 28.55
US$ 21.61
